The economic burden of epilepsy in Korea, 2010

Jaehun Jung, Hye Young Seo, Young Ae Kim, In Hwan Oh, Yo Han Lee, Seok-Jun Yoon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

Original languageEnglish
Pages (from-to)293-299
Number of pages7
JournalJournal of Preventive Medicine and Public Health
Volume46
Issue number6
DOIs
Publication statusPublished - 2013 Nov 1

Fingerprint

Korea
Epilepsy
Economics
Costs and Cost Analysis
National Health Programs
International Classification of Diseases
Ambulatory Care Facilities
Cause of Death

Keywords

  • Cost of illness
  • Epilepsy
  • Prevalence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

The economic burden of epilepsy in Korea, 2010. / Jung, Jaehun; Seo, Hye Young; Kim, Young Ae; Oh, In Hwan; Lee, Yo Han; Yoon, Seok-Jun.

In: Journal of Preventive Medicine and Public Health, Vol. 46, No. 6, 01.11.2013, p. 293-299.

Research output: Contribution to journalArticle

Jung, Jaehun ; Seo, Hye Young ; Kim, Young Ae ; Oh, In Hwan ; Lee, Yo Han ; Yoon, Seok-Jun. / The economic burden of epilepsy in Korea, 2010. In: Journal of Preventive Medicine and Public Health. 2013 ; Vol. 46, No. 6. pp. 293-299.
@article{9feac139dba14073a10c7a746befd77d,
title = "The economic burden of epilepsy in Korea, 2010",
abstract = "Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5{\%} of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.",
keywords = "Cost of illness, Epilepsy, Prevalence",
author = "Jaehun Jung and Seo, {Hye Young} and Kim, {Young Ae} and Oh, {In Hwan} and Lee, {Yo Han} and Seok-Jun Yoon",
year = "2013",
month = "11",
day = "1",
doi = "10.3961/jpmph.2013.46.6.293",
language = "English",
volume = "46",
pages = "293--299",
journal = "Journal of Preventive Medicine and Public Health",
issn = "1975-8375",
publisher = "Korean Society for Preventive Medicine",
number = "6",

}

TY - JOUR

T1 - The economic burden of epilepsy in Korea, 2010

AU - Jung, Jaehun

AU - Seo, Hye Young

AU - Kim, Young Ae

AU - Oh, In Hwan

AU - Lee, Yo Han

AU - Yoon, Seok-Jun

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

AB - Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

KW - Cost of illness

KW - Epilepsy

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84892683188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892683188&partnerID=8YFLogxK

U2 - 10.3961/jpmph.2013.46.6.293

DO - 10.3961/jpmph.2013.46.6.293

M3 - Article

C2 - 24349650

AN - SCOPUS:84892683188

VL - 46

SP - 293

EP - 299

JO - Journal of Preventive Medicine and Public Health

JF - Journal of Preventive Medicine and Public Health

SN - 1975-8375

IS - 6

ER -